(Total Views: 102)
Posted On: 04/24/2023 12:05:47 PM
Post# of 107272
$SNGX News Article - Soligenix Submits Type A Meeting Request to U.S. FDA to Review Proposed Study Design for a Second Phase 3 Study Evaluating HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma https://marketwirenews.com/news-releases/soli...69198.html
(0)
(0)
My Twitter: WhyteStocks
